Rewriting the rules for care of MDS and AML patients in the time of COVID-19
{{output}}
The care of patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) has been radically altered by COVID-19, especially in New York City, the epicenter of the pandemic. Here we summarize how telemedicine, virtual visits, delayed transfusi... ...
